EU Vigilance has many years of experience in drug safety and pharmacovigilance. Throughout years in the industry EU Vigilance has cooperated with clients from the US, Europe and Middle East.
As well as training courses provided in-house for our clients, our Directors have provided training as follows
given by Prof. Dr. Paolo Biffignandi and Dr. Axel Wenzel
Speaker |
Date |
Organisation |
Title |
Prof. Dr. Paolo Biffignandi |
January 2014 |
European Generic Medicine Association (EGA) , London |
The 7th EGA Pharmacovigilance Discussion Forum |
Prof. Dr. Paolo Biffignandi |
June 2013 |
( European Medicines Agency (EMA), London |
The 1st Information Day on Periodic Safety Update Reports |
Prof. Dr. Paolo Biffignandi |
May 2013 |
EudraVigilance, London |
The 14th EudraVigilance Info Day |
Dr. Axel Wenzel |
February 2013 |
TOPRA CRED, London |
New PV Legislation: The RMP & workshop |
Dr. Axel Wenzel |
January 2013 |
University Essen/Duisburg |
New clinical Trail Regulation, what´s new in PV? |
Dr. Axel Wenzel |
December 2012 |
European Association of Pharma Biotechnology (EAPB), Regulatory SIG, |
Webinar: GVP and New clin. Trail Regulation |
Prof. Dr. Paolo Biffignandi |
October 2012 |
EudraVigilance, London |
The 13th EudraVigilance Info Day |
Prof. Dr. Paolo Biffignandi |
January 2012 |
European Generic Medicine Association (EGA) , London |
The 5th EGA Pharmacovigilance Discussion Forum |
Prof. Dr. Paolo Biffignandi |
January 2012 |
Austrian Agency for Health and Food Safety (AGES), Vienna |
The Extended EudraVigilance Medicinal Product Dictionary Training Course |
Prof. Dr. Paolo Biffignandi |
May 2010 |
International Society of Pharmacovigilance (ISOP) & University Belgrad |
Basic concepts in Pharmacovigilance |
Dr. Axel Wenzel |
March 2009 |
Health Sciences, Istanbul |
DDPS, RMP and other PV issues in EU MAAs |
Dr. Axel Wenzel |
August 2008 |
Saudi Food & Drug Authory, Riyoaoh, SA |
European Drug Regulatory Environment – PV Basics |
Dr. Axel Wenzel |
January 2007 |
Health Sciences, Ankara |
Drug Safety |
Dr. Axel Wenzel |
November 2005 |
Pharmaceutical Information and Pharmacovigilance Association (PIPA), UK |
What regulators should know about PV |
EU Vigilance